Details for Patent: 6,784,177
✉ Email this page to a colleague
Summary for Patent: 6,784,177
Title: | Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Abstract: | The present invention provides methods of treating and preventing mortality associated with heart failure in an African American patient with hypertension, and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present invention, the hydralazine compound is preferably hydralazine or a pharmaceutically acceptable salt thereof. Preferred methods of the invention comprise administering hydralazine or a pharmaceutically acceptable salt thereof and isosorbide dinitrate. |
Inventor(s): | Cohn; Jay N. (Minneapolis, MN), Carson; Peter (Chevy Chase, MD) |
Assignee: | Nitro Med, Inc. (Bedford, MA) |
Application Number: | 10/210,113 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; Device; |
Drugs Protected by US Patent 6,784,177
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,784,177
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 7365900 | ⤷ Try a Trial | |||
Canada | 2383974 | ⤷ Try a Trial | |||
European Patent Office | 1212053 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 0117528 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |